Gerstein Fisher’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$5.07M Sell
48,471
-9,065
-16% -$981K 0.62% 26
2016
Q2
$5.67M Sell
57,536
-2,241
-4% -$232K 0.74% 19
2016
Q1
$5.98M Sell
59,777
-532
-0.9% -$54.8K 0.82% 17
2015
Q4
$7.22M Sell
60,309
-2,365
-4% -$274K 1.01% 12
2015
Q3
$6.78M Buy
62,674
+941
+2% +$117K 1.01% 9
2015
Q2
$7.14M Sell
61,733
-6,631
-10% -$758K 1.16% 7
2015
Q1
$7.88M Buy
68,364
+6,042
+10% +$722K 1.3% 8
2014
Q4
$7.02M Sell
62,322
-4,220
-6% -$445K 1.14% 11
2014
Q3
$6.31M Buy
66,542
+35,830
+117% +$3.23M 1.11% 9
2014
Q2
$2.64M Buy
30,712
+126
+0.4% +$9.58K 0.5% 35
2014
Q1
$2.13M Sell
30,586
-39,902
-57% -$3.16M 0.43% 44
2013
Q4
$26.6M Buy
70,488
+64,248
+1,030% +$5.08M 0.99% 20
2013
Q3
$481K Buy
+6,240
New +$437K 0.1% 185

Other funds holding CELG

Gerstein Fisher's CELG Position: Q3 2016 in Review

Gerstein Fisher reduced its Celgene Corp (CELG) stake by 16% in Q3 2016, selling an estimated $981K and leaving 48,471 shares worth $5.07M. The position accounts for 0.62% of the portfolio, ranked #26.

Gerstein Fisher first reported a position in CELG in Q3 2013 and has held it in 13 quarters since. The position peaked at $26.6M in Q4 2013. 1,277 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

  • Gerstein Fisher held 48,471 shares of Celgene Corp worth $5.07M as of Q3 2016.
  • Gerstein Fisher sold 9,065 Celgene Corp shares in Q3 2016, an estimated $981K.
  • Celgene Corp made up 0.62% of Gerstein Fisher's portfolio in Q3 2016, its #26 holding.
  • Gerstein Fisher first reported a position in Celgene Corp in Q3 2013 and has held it in 13 quarters since.
  • Gerstein Fisher's Celgene Corp position peaked at $26.6M in Q4 2013.
  • 1,277 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on Gerstein Fisher's 13F filing for Q3 2016, filed 15 Nov 2016.